Aptamer developed by HKBU for treating rare bone disease 'X-linked hypophosphatemia' receives Orphan Drug Designation and Rare Pediatric Disease Designation by U.S. FDA

Aptamer developed by HKBU for treating rare bone disease 'X-linked hypophosphatemia' receives Orphan Drug Designation and Rare Pediatric Disease Designation by U.S. FDA

HONG KONG, Dec. 23, 2024 /PRNewswire/ -- A research led by Hong Kong Baptist University (HKBU) and the Shanghai Sixth People's Hospital Affiliated to School of Medicine at Shanghai Jiao Tong University (Shanghai Sixth People's Hospital) has...

CPIC Life (HK): Based in Hong Kong and Serving the Greater Bay Area via Upgrades of Products/ Services

CPIC Life (HK): Based in Hong Kong and Serving the Greater Bay Area via Upgrades of Products/ Services

SHANGHAI, Dec. 21, 2024 /PRNewswire/ -- In December 2024, China Pacific Insurance Company(CPIC) celebrates the 15th anniversary of its H-share listing. In mid-November 2021, China Pacific Life Insurance (Hong Kong) Company Limited ("CPIC Life (HK)")...

Tam Jai lnt'l Wins HKAEE Award and Multiple ESG Accolades

Tam Jai lnt'l Wins HKAEE Award and Multiple ESG Accolades

For Sustainability Achievement HONG KONG, Dec. 18, 2024 /PRNewswire/ -- Tam Jai International Co. Limited ("TJI", "Tam Jai International", "Tam Jai" or the "Company", and together with its subsidiaries, the "Group"; HKEX stock code: 2217), one of...

Fosun International Awarded TVB's Highest Honor "Outstanding ESG Award"

Fosun International Awarded TVB's Highest Honor "Outstanding ESG Award"

HONG KONG, Dec. 18, 2024 /PRNewswire/ -- On 13 December 2024, the "TVB ESG Awards" ceremony, hosted by Television Broadcasts Limited (hereinafter referred to as "TVB"), was held at the Hong Kong Convention and Exhibition Centre. Fosun International...

JA Solar Secures EcoVadis Silver Medal, Joining Top 6% of Global Companies

JA Solar Secures EcoVadis Silver Medal, Joining Top 6% of Global Companies

BEIJING, Dec. 18, 2024 /PRNewswire/ -- JA Solar recently achieved a historic milestone by scoring an impressive 73 points—the highest in its history—in the globally recognized EcoVadis Corporate Social Responsibility (CSR) assessment. This...

CLL Systems Empowers Digital Innovation at The BrandLaureate DigiTech (Digital & Technology) BestBrands Awards 2024

CLL Systems Empowers Digital Innovation at The BrandLaureate DigiTech (Digital & Technology) BestBrands Awards 2024

KUALA LUMPUR, Malaysia, Dec. 17, 2024 /PRNewswire/ -- CLL Systems Sdn Bhd, one of Malaysia's premier IT solutions providers, proudly received The BrandLaureate DigiTech (Digital & Technology) BestBrands Award 2024, a recognition of the company's...

DPC Dash - Domino's Pizza China Wins Seven-Star Award for Outstanding Contributions in Food Safety & Public Health for the Fourth Year

DPC Dash - Domino's Pizza China Wins Seven-Star Award for Outstanding Contributions in Food Safety & Public Health for the Fourth Year

HONG KONG, Dec. 17, 2024 /PRNewswire/ -- DPC Dash – Domino's Pizza China ("DPC Dash" or the "Company") (1405.HK), the exclusive master franchisee for Domino's Pizza in the China Mainland, the Hong Kong Special Administrative Region of China, and the...

Accropeutics Inc. Announces U.S. FDA Clearance of IND Application for RIPK2 Inhibitor AC-101

Accropeutics Inc. Announces U.S. FDA Clearance of IND Application for RIPK2 Inhibitor AC-101

Company to conduct a Phase II multi-regional clinical trial (MRCT) for the treatment of Ulcerative Colitis (UC) A Phase Ib Study of AC-101 for Ulcerative Colitis (UC) has been initiated in China AC-101 demonstrated a favorable safety and PK/PD...

15 YEARS OLD STUDENTS FROM JOHOR BAGS MOST INNOVATIVE AWARD IN SAMSUNG SOLVE FOR TOMORROW 2024

15 YEARS OLD STUDENTS FROM JOHOR BAGS MOST INNOVATIVE AWARD IN SAMSUNG SOLVE FOR TOMORROW 2024

Green Tech Innovations Take Center Stage in STEM Competition KUALA LUMPUR, Malaysia, Dec. 13, 2024 /PRNewswire/ -- Team Terralnnovators from Johor, made up of three 15-year-old students, has been crowned the winner of the sixth edition of Samsung...

CureGene Received Clinical Trial Approval in China for CG-0255 for Injection - A Novel Antiplatelet Therapy

CureGene Received Clinical Trial Approval in China for CG-0255 for Injection - A Novel Antiplatelet Therapy

SHANGHAI, Dec. 12, 2024 /PRNewswire/ -- CureGene Pharmaceutical ("CureGene"), a biotechnology company dedicated to innovative treatments for critical unmet medical needs in cardio-cerebrovascular and antiviral disease, proudly announces the approval...

  • 1
  • 2
  • 3
  • menu
    menu